カテゴリ： , , MarketLine

Alexion Pharmaceuticals, Inc.

◆英語タイトル：Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3503
◆発行会社（調査会社）：MarketLine
◆発行日：2019
◆ページ数：54
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Alexion Pharmaceuticals, Inc. (Alexion or ‘the company’) is a biopharmaceutical company involved in the innovation, development and commercialization of life-transforming therapeutic products. The company focuses on the therapeutic areas such as Hematology, Neurology, Nephrology and Metabolic disorders.Its product portfolio comprises Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG); Strensiq (asfotase alfa) for the treatment of patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company primarily operates in the US, Europe and Asia-Pacific. It is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Alexion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Alexion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Alexion Pharmaceuticals, Inc.: Company Overview
Alexion Pharmaceuticals, Inc.: Overview and Key Facts
Alexion Pharmaceuticals, Inc.: Overview
Alexion Pharmaceuticals, Inc.: Key Facts
Alexion Pharmaceuticals, Inc.: Key Employees
Alexion Pharmaceuticals, Inc.: Key Employee Biographies
Alexion Pharmaceuticals, Inc.: Major Products and Services
Alexion Pharmaceuticals, Inc.: Company History
Alexion Pharmaceuticals, Inc.: Management Statement
Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Alexion Pharmaceuticals, Inc.: Key Competitors
Alexion Pharmaceuticals, Inc.: Company Analysis
Alexion Pharmaceuticals, Inc.: Business Description
Alexion Pharmaceuticals, Inc.: SWOT Analysis
Alexion Pharmaceuticals, Inc.: SWOT Overview
Alexion Pharmaceuticals, Inc.: Strengths
Alexion Pharmaceuticals, Inc.: Weaknesses
Alexion Pharmaceuticals, Inc.: Opportunities
Alexion Pharmaceuticals, Inc.: Threats
Alexion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Alexion Pharmaceuticals, Inc.: Financial Deals Overview
Alexion Pharmaceuticals, Inc.: Targets and Partners
Alexion Pharmaceuticals, Inc.: Top Deals 2015 – 2019YTD*
Alexion Pharmaceuticals, Inc.: Advisors
Alexion Pharmaceuticals, Inc.: Top Legal Advisors
Alexion Pharmaceuticals, Inc.: Top Financial Advisors
Alexion Pharmaceuticals, Inc.: Mergers and Acquisitions
Alexion Pharmaceuticals, Inc.: Partnership
Alexion Pharmaceuticals, Inc.: Divestments
Alexion Pharmaceuticals, Inc.: Recent Developments
Alexion Pharmaceuticals, Inc.: News and Events Summary
Alexion Pharmaceuticals, Inc.: Contracts
Alexion Pharmaceuticals, Inc.: Corporate Governance
Alexion Pharmaceuticals, Inc.: Financial Deals
Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Alexion Pharmaceuticals, Inc.: Research & Development
Alexion Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Alexion Pharmaceuticals, Inc.: Key Facts
Table 2: Alexion Pharmaceuticals, Inc.: Key Employees
Table 3: Alexion Pharmaceuticals, Inc.: Company History
Table 4: Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Alexion Pharmaceuticals, Inc.: Key Competitors
Table 6: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Alexion Pharmaceuticals, Inc.: Targets and Partners
Table 10: Alexion Pharmaceuticals, Inc.: Top Deals 2015 - 2019YTD*
Table 11: Alexion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Alexion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: Alexion Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: Alexion Pharmaceuticals, Inc.: News and Events Summary
Table 19: Alexion Pharmaceuticals, Inc.: Contracts
Table 20: Alexion Pharmaceuticals, Inc.: Corporate Governance
Table 21: Alexion Pharmaceuticals, Inc.: Financial Deals
Table 22: Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Table 23: Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 24: Alexion Pharmaceuticals, Inc.: Research & Development
Table 25: Alexion Pharmaceuticals, Inc.: Strategy and Operations

★海外企業調査レポート[Alexion Pharmaceuticals, Inc.]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Optus Inc：企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Oxford Nanopore Technologies Ltd-医療機器分野：企業M&A・提携分析
    Summary Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., is a biotechnology diagnostic company. It develops technologies for molecular detection and analysis. The company offers a range of nanopores and devices such as MinION, PromethION and GridION used for the ana …
  • GR. Sarantis S.A.：企業の戦略・SWOT・財務情報
    GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report Summary GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Windtree Therapeutics Inc (WINT)-医療機器分野：企業M&A・提携分析
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Spineway SAS (ALSPW)：企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Kohl’s Corporation (KSS)：企業の財務・戦略的SWOT分析
    Kohl's Corporation (KSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Johnson & Johnson Vision Care Inc：医療機器：M&Aディール及び事業提携情報
    Summary Johnson & Johnson Vision Care Inc (J&J Vision Care), a subsidiary of Johnson & Johnson, is a medical device company that manufactures and markets contact lens and spectacle products. The company offers products such as disposable contact lens; contact lenses with astigmatism; contact lenses …
  • Luye Pharma Group Co Ltd (2186)：製薬・医療：M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • Metropolitan Bank & Trust Company (MBT)：企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • International Dairy Queen, Inc.：企業の戦略・SWOT・財務情報
    International Dairy Queen, Inc. - Strategy, SWOT and Corporate Finance Report Summary International Dairy Queen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Trican Well Service Ltd (TCW)：石油・ガス：M&Aディール及び事業提携情報
    Summary Trican Well Service Ltd (Trican) is an oilfield services company, which provides specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, coiled tubin …
  • Baoviet Holdings：企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sanlam Kenya Plc：企業の戦略・SWOT・財務情報
    Sanlam Kenya Plc - Strategy, SWOT and Corporate Finance Report Summary Sanlam Kenya Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Best Doctors Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Best Doctors Inc (Best Doctors), a subsidiary of Teladoc, Inc, is a healthcare service provider that offers medical services. The company provides services such as inter-consultation and critical care inter-consultation services for multi-trauma, spinal cord injuries, traumatic brain injurie …
  • Owens‑Illinois, Inc.：企業の戦略・SWOT・財務情報
    Owens‑Illinois, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens‑Illinois, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tobu Railway Co Ltd：戦略・SWOT・企業財務分析
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • National Company KazMunayGas：企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • First Ship Lease Trust (D8DU)：企業の財務・戦略的SWOT分析
    First Ship Lease Trust (D8DU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Otto Bock HealthCare GmbH：企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ECO Animal Health Group Plc (EAH)：企業の財務・戦略的SWOT分析
    Summary ECO Animal Health Group Plc (ECO) is a veterinary products manufacturer that offers therapeutic products. The company develops, registers and markets pharmaceutical products and chemicals for animal health markets. ECO produces proprietary patented drugs that are used for the treatment of re …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆